咨询热线:028-85335741
药品资讯网--新药研发行业门户!
- 行业资讯
- 药品资讯网--医药招商、医药中间体、仪器设备、药包材信息发布平台!
- 专业资料

- 中国(天津)国际生物医药产业
主办:天津市滨海新区人民政府 天津市食品药品监督管理局
天津市卫生局 天津市医药国际交流协会
日期:2013/06/25-06/28 
- 第十四届中国国际家庭医疗、保
主办:中华人民共和国商务部 中华人民共和国卫生部 中华人民共和国质检总局 中国医疗保健国际交流促进会 中国医促会亚健康专业委员会
日期:2013/04/07-04/09 
- 2012中国(苏州)国际医药
主办:全国卫生产业企业管理协会 江苏省医院协会 江苏省保健养生业协会
日期:2012/11/09-11/11
- (E)-3-phenyl-N-[(1R)-2,2,,2-trichloro-1-morpholin
- STK191919,BAS 05948090,4-Chloro-N-(2-pyrrolidin-1-
- Oprea1_395862,BAS 04050480,T0511-0759,2-(2-Oxo-2-p
- ZINC00748646 N-[(2R)-butan-2-yl]-5-[(2-ethylphenyl
- ethyl,4-[[5-[(4-morpholin-4-ylphenyl)methylidene]
- Oprea1_013741,Oprea1_392559,STK098519, ethyl,5-met
- (6S,9R)-5-acetyl-9-(4-diethylaminophenyl)-6-(4-me
- ZINC00696933 N-[4-[3-ethoxy-5-(2-methylphenyl)-1,2
- Oprea1_356780,Oprea1_396131,BAS 00344558,2-Methoxy
- 4-methoxy-N-[(E)-3-(2-methoxyphenyl)prop-2-enyl]-
- STK316954,ZINC00696009,AK-968/40735036, 3-chloro-N
- ZINC00801596 (5R)-5-(3-ethoxyphenyl)-3-hydroxy-1-(
- Oprea1_517892,Oprea1_836297,ZINC00797748,BAS 02153
- STK341355,ZINC00815190,BAS 09530245,AN-329/4321125
- ethyl,(2E,5R)-5-(3,,4-dimethoxyphenyl)-2-[(3-etho
- Oprea1_626154,EU-0073913, 1-[4-[2-(1-hydroxycycloh
- Oprea1_284661,Oprea1_779601,STOCK2S-76158,ZINC0077
- 4-tert-butyl-N-[2-[[5-tert-butyl-2-(4-methylpheny
- STK128300,ZINC00665823,BAS 06740661,AH-487/4214509
- 2-methoxy-6-[[2-methyl-4-(5-methyl-1,,3-benzoxazo
- ZINC00796998,BAS 05988134,ST5080891, N-(3-chloro-2
- N-[2-[[2-(4-fluorophenyl)-5-phenylpyrazol-3-yl]am
- ZINC00713912 ethyl,(4R)-2-amino-1-(4-chlorophenyl)
- AK-968/37202038 5-(4-bromophenyl)-N-(3-hydroxyphen
- (2S)-1-[[1-(3,,4-dimethoxyphenyl)cyclopentyl]meth
- BAS 06208766 2-[7-[(4-chlorophenyl)methyl]-1,3-dim
- Oprea1_328155,ZINC00800679,BAS 06330881,ST5279794,
- MLS000529002,ZINC00815303,BAS 09530491,SMR00012147
- N-(furan-2-ylmethyl)-N-[3-[4-(4-methoxyphenyl)pip
- Oprea1_127355,BAS 04057038,ST5018739,(3-Benzyloxy-
- N-[4-(dihydroxyamino)benzoyl]imino-2-hydroxy-4-ox
- BAS 02138500 N-(4-chloro-3-nitrophenyl)-2-[[4-ethy
- Clomoxir ethyl(Rec INNM), B-80727(free acid Na sal
- Vadocaine hydrochloride, K-242-HCl, ORK-242-HCl,72
- Cisplatin, DDP-H, NSC-119875, CPDC, CACP, CDDP, Ci
- Oltipraz, RP-35972,64224-21-1,4-Methyl-5-pyrazinyl
- RX-77368,76820-40-1,L-Pyroglutamyl-L-Histidyl-L-3,
- CV-1808,53296-10-9, 53296-11-0 (HCl),2-Anilinoaden
- Azelaic acid, ZK-62498, AGN-191861, SH-441, Finace
- LL-11204, DL-204-IT,55308-64-0,2-(3-Ethoxyphenyl)-
- Nordidemnin, Didemnin B, NorD, NSC-325319,77327-05
- Detomidine hydrochloride, Domosedan,90038-01-0, 76
- LY-178207(free base), GYKI-14451,69201-89-4 (free
- LT-1,85894-16-2,N-Hydroxy-2-(2-pyridinylmethylene)
- GYKI-11679, RGH-5526,69579-13-1,1-(6-Morpholino-3-
- Riodoxol,19403-92-0,2,4,6-Triiodoresorcine; 2,4,6-
- Setoperone(Rec INN; USAN), R-52245,86487-64-1,6-[2
- SK&F-88046,80565-83-9, 80566-05-8 (Na salt),N7-(3-
- Suproclone(Rec INN; USAN), 37162-RP, RP-37162,7759
- TetramethylHES,74385-27-6,1,1,2,2-Tetramethyl-1,2-
- Rebamipide, Pramipide, Proamipide, OPC-12759, Muco
- Caracemide, NSC-253272,81424-67-1,N-[(Methylamino)
- Fezolamine fumarate, Win-41528-2,80410-37-3, 80410
- DAMP-ES,78825-25-9, 31935-08-7 (free base),5-(1-Ad
- Moxadolen, Lu-253,56232-20-3,4-Oxa-5-(N-methylcarb
- Glutaurine, Litoralon,56488-60-9,gamma-L-Glutamyl-
- Mirtazapine, Azamianserin, Org-3770, Remeron SolTa
- Clofilium phosphate, LY-150378,68379-03-3,[4-(p-Ch
- M-6434,77636-92-1, 77636-84-1 (monoHCl),2-[(5-Chlo
- Cicloprolol hydrochloride, SL-7517710,94651-09-9 (
- Methosorbinil, M-79175, E-0722,82319-87-7 (racemat
- 386/1634, FCE-386/1634,70651-76-2,1,4-Diethyl-5-(N
- LM-1554,,2-Chloromethyl-5,6,7,8-tetrahydrobenzo[b]
- Nitidine chloride, NSC-146397(anhydrous),13063-04-